Unknown

Dataset Information

0

Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.


ABSTRACT: BACKGROUND:Conflicting data exist regarding the effect of pregnancy on steady-state nevirapine pharmacokinetics (PK), although steady-state nevirapine concentrations during pregnancy have never been characterized in sub-Saharan Africa. METHODS:This was a longitudinal intensive PK study in Ugandan pregnant women receiving nevirapine-based antiretroviral therapy. Participants underwent intensive 12-hour PK sampling during the second trimester (T2; n = 4), third trimester (T3; n = 15) and 6 weeks postpartum (PP; n = 15). HIV-1 RNA was performed within 2 weeks of each visit. Nevirapine C12 above 3000 ng/mL was classified as optimal based on the suggested value for therapeutic drug monitoring. RESULTS:The pharmacokinetics of nevirapine were influenced by pregnancy, demonstrated by a 20% reduction in the maximum concentration, minimum concentration (C12), and area under the curve between T3 and PP visits (P = 0.001, P = 0.011 and P = 0.005, respectively). Ten subjects (66.7%) had C12 values <3000 ng/mL during T3. Of these participants, 7 partcipant's C12 concentrations increased to >3000 ng/mL during the PP visit. HIV-1 RNA were <1000 copies per milliliter at T3 and <400 copies per milliliter at PP in all patients. CONCLUSIONS:Nevirapine exposure was reduced in Ugandan women during their third trimester compared with the same women PP, however, HIV RNA remained <1000 copies per milliliter. The long-term impact of intermittent suboptimal nevirapine concentrations during pregnancy is unknown.

SUBMITTER: Lamorde M 

PROVIDER: S-EPMC3594885 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.

Lamorde Mohammed M   Byakika-Kibwika Pauline P   Okaba-Kayom Violet V   Flaherty John P JP   Boffito Marta M   Namakula Rhoda R   Ryan Mairin M   Nakabiito Clemensia C   Back David J DJ   Khoo Saye S   Merry Concepta C   Scarsi Kimberly K KK  

Journal of acquired immune deficiency syndromes (1999) 20101101 3


<h4>Background</h4>Conflicting data exist regarding the effect of pregnancy on steady-state nevirapine pharmacokinetics (PK), although steady-state nevirapine concentrations during pregnancy have never been characterized in sub-Saharan Africa.<h4>Methods</h4>This was a longitudinal intensive PK study in Ugandan pregnant women receiving nevirapine-based antiretroviral therapy. Participants underwent intensive 12-hour PK sampling during the second trimester (T2; n = 4), third trimester (T3; n = 15  ...[more]

Similar Datasets

| S-EPMC2681511 | biostudies-literature
| S-EPMC3586376 | biostudies-literature
| S-EPMC5700353 | biostudies-literature
| S-EPMC5491286 | biostudies-literature
| S-EPMC2922986 | biostudies-literature
| S-EPMC3101396 | biostudies-literature
| S-EPMC3554734 | biostudies-literature
| S-EPMC4291392 | biostudies-literature
| S-EPMC3001850 | biostudies-literature
| S-EPMC4232039 | biostudies-literature